Clinical Trial

Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis

Study acronym: BEAT-OP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Osteoporosis is a systemic bone disorder characterised by a reduced bone mass and structural deterioration, increasing the risk of fragility fractures, particularly in women post-menopause. Bone mass and structure can be assessed by scans. Antiresorptive medications are commonly prescribed to reduce bone resorption, preventing further bone loss and thus reducing the possibility of fracture. Exercise can also benefit bone mass and structure but current evidence do not show whether exercise is more, or less, effective in combination with antiresorptive medication. This study will compare the effect of a brief, home-based exercise programme on bone mineral and structural properties in women taking/ not taking antiresorptive medication.
Trial Details
NCT Number NCT07267325
Lead Sponsor Loughborough University
Collaborators: University of Sheffield, University of Cambridge
Conditions Osteoporosis in Post-menopausal Women
Enrollment 110 participants
Start Date 2026-01-01
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-05